---
figid: PMC2594010__nihms66966f2
figlink: /pmc/articles/PMC2594010/figure/F2/
number: F2
caption: Wnt ligand interaction with the LRP receptor complex activates the pathway
  and β-catenin levels increase intracellularly. β-catenin translocates to the nucleus
  where it forms a transcriptional regulatory complex with TCF/LEF to activate transcription
  of cyclin D1, c-Myc and other downstream targets. E-cadherin negatively regulates
  Wnt signaling. E-cadherin binds and sequesters β-catenin to the plasma cell membrane
  at the adherens junctions, rendering it unavailable for transcriptional activity.
  Maintenance of low β-catenin levels by axin occur in the absence of Wnt ligand.
  Axin coordinates the β-catenin destruction complex (casein kinase 1a (Ck1a), glycogen
  synthase kinase 3β (Gsk3β), the tumor suppressor adenomatous polyposis coli (APC)
  and protein phosphatase 2A (PP2A)). Together, these components lead to the sequential
  phosphorylation of β-catenin and eventual proteasomal degradation.
pmcid: PMC2594010
papertitle: 'Regulation of metastasis in colorectal adenocarcinoma: A collision between
  development and tumor biology.'
reftext: J. Joshua Smith, et al. Surgery. ;144(3):353-366.
pmc_ranked_result_index: '20739'
pathway_score: 0.9447834
filename: nihms66966f2.jpg
figtitle: 'Regulation of metastasis in colorectal adenocarcinoma: A collision between
  development and tumor biology'
year: ''
organisms:
- Homo sapiens
ndex: 68957245-df00-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2594010__nihms66966f2.html
  '@type': Dataset
  description: Wnt ligand interaction with the LRP receptor complex activates the
    pathway and β-catenin levels increase intracellularly. β-catenin translocates
    to the nucleus where it forms a transcriptional regulatory complex with TCF/LEF
    to activate transcription of cyclin D1, c-Myc and other downstream targets. E-cadherin
    negatively regulates Wnt signaling. E-cadherin binds and sequesters β-catenin
    to the plasma cell membrane at the adherens junctions, rendering it unavailable
    for transcriptional activity. Maintenance of low β-catenin levels by axin occur
    in the absence of Wnt ligand. Axin coordinates the β-catenin destruction complex
    (casein kinase 1a (Ck1a), glycogen synthase kinase 3β (Gsk3β), the tumor suppressor
    adenomatous polyposis coli (APC) and protein phosphatase 2A (PP2A)). Together,
    these components lead to the sequential phosphorylation of β-catenin and eventual
    proteasomal degradation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BTRC
  - SIRT1
  - SIRT5
  - WNT1
  - AXIN1
  - CTNNB1
  - HDAC8
  - HDAC11
  - HDAC6
  - APC
  - MYC
  - HDAC9
  - AXIN2
  - HDAC4
  - HDAC2
  - CCND1
  - HDAC1
  - EP300
  - HDAC5
  - HDAC3
  - SIRT7
  - HDAC10
  - SIRT2
  - HDAC7
  - SIRT4
  - SIRT3
  - SIRT6
  - CDH1
  - GSK3B
  - Cancer
genes:
- word: B-TRCP
  symbol: betaTrCP
  source: hgnc_alias_symbol
  hgnc_symbol: BTRC
  entrez: '8945'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT1
  entrez: '23411'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT5
  entrez: '23408'
- word: (Wnt1
  symbol: WNT1
  source: hgnc_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: (Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC8
  entrez: '55869'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC11
  entrez: '79885'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC6
  entrez: '10013'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC9
  entrez: '9734'
- word: (Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC4
  entrez: '9759'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC2
  entrez: '3066'
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC1
  entrez: '3065'
- word: CPB/p300
  symbol: p300
  source: hgnc_alias_symbol
  hgnc_symbol: EP300
  entrez: '2033'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC5
  entrez: '10014'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC3
  entrez: '8841'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT7
  entrez: '51547'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC10
  entrez: '83933'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT2
  entrez: '22933'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC7
  entrez: '51564'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT4
  entrez: '23409'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT3
  entrez: '23410'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT6
  entrez: '51548'
- word: E-cadherin
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC2594010__F2
redirect_from: /figures/PMC2594010__F2
figtype: Figure
---
